CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +21,000 | $146.03 | $3.1M | 29,118 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −98 | $432.09 | $42K | 29,020 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,074 | $432.86 | $465K | 27,946 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,512 | $433.78 | $656K | 26,434 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,679 | $434.96 | $730K | 24,755 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −6,088 | $435.81 | $2.7M | 18,667 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −7,317 | $436.78 | $3.2M | 11,350 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,752 | $437.74 | $1.2M | 8,598 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −360 | $438.50 | $158K | 8,238 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $439.51 | $53K | 8,118 |
| 2025-11-04 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Options 10b5-1 | −21,000 | 31,312 | ||
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −964 | $432.55 | $417K | 13,661 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,687 | $433.52 | $1.2M | 10,974 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,918 | $434.68 | $1.3M | 8,056 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −3,204 | $435.52 | $1.4M | 4,852 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,121 | $436.45 | $926K | 2,731 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −890 | $437.70 | $390K | 1,841 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −585 | $438.34 | $256K | 1,256 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −575 | $439.35 | $253K | 681 |
Page 186 of 214 · 4,273 trades